# EDGAR Filing Document

**Accession Number:** 0001738021
**File Stem:** 0001193125-26-001593
**Filing Date:** 2026-1
**Character Count:** 1964
**Document Hash:** ae16bbf759a0998fa15565105a727351
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-001593.hdr.sgml**: 20260320

**ACCESSION NUMBER**: 0001193125-26-001593

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260105

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Compass Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001738021
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 80 GUEST STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02135
- **BUSINESS PHONE:** 617-500-8099

**MAIL ADDRESS:**
- **STREET 1:** 80 GUEST STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02135

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Olivia Ventures, Inc.
- **DATE OF NAME CHANGE:** 20180419

**COMPASS THERAPEUTICS, INC.** 

**80 GUEST STREET, SUITE 601** 

**BOSTON, MASSACHUSETTS 02135** 

**<u>VIA EDGAR</u>**

January 5, 2026

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Compass Therapeutics, Inc.**  |

---

**Registration Statement on Form S-3 (File No. 333-292491)** 

**Acceleration Request:** 

**Requested Date: January 7, 2026** 

**Requested Time: 10:00 A.M. Eastern Time** 

Dear Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Compass Therapeutics, Inc. (the "Company") hereby requests that the Registration Statement on Form S-3 (File No. 333-292491) (the "Registration Statement") be declared effective at the "Requested Date" and "Requested Time" set forth above or as soon thereafter as practicable.

---

| |
|:---|
| Sincerely, |
| COMPASS THERAPEUTICS, INC. |
| /s/ Barry Shin |
| Barry Shin |
| *Chief Financial Officer* |

---